论文部分内容阅读
Circulating Tumor Cells(CTCs)have been demonstrated to be excellent biomarkers for cancer diagnosis and prognosis.During the past ten years,tremendous amounts of effort have been invested in developing various microfluidic platforms based on different separation principles ranging from sized/deformity oriented techniques to immunocapture methods for CTC enrichment.